Polpharma Pharmaceutical Works - API Manufacturer

drukuj

Strategy and goals   

 

The Polpharma Fine Chemicals Business Unit is building its position as an active supplier of generic APIs on the global market. The company strives to become a leading player in this market segment.

Vertical integration with the Pharma Business Unit provides us an advantage in the area of quality and cost. We simultaneously and consistently prove the flexibility of the services provided.

 

Our goal is to manage innovation with good practices, understanding customers’ needs, and providing the best solutions for them.
 

We are focusing our efforts on modernizing the API portfolio and expanding it with new, attractive products.

Our mission is the reliable delivery of APIs as early as possible in the product development phase so that our customers can improve their time to market with the secured quality of new molecules that lose patent protection. Our goal is to maintain a good relationship and cost competitive service throughout the product's entire life cycle.

Our greatest asset is our highly skilled and well motivated staff. We are striving in embrace new knowledge and information trends that can in turn make talented workers more effective.

We look outside company boundaries for ideas, knowledge and technology. We have developed alliances in a collaborative relationship with R&D centers and labs promoting effective alliance leadership and collaboration.

Gain an advantage from our APIs

Latest news

CEP for Baclofen available

Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...

Polpharma – the most innovative company in Poland

Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...

Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex

Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...

Co-operation between Polpharma and RPG Life Sciences

Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...
© POLPHARMA S.A. All rights reserved.
Realizacja: Ideo